FDA approves Inqovi for acute myeloid leukemia

The U.S. Food and Drug Administration has approved Taiho Oncology's Inqovi (decitabine and cedazuridine) plus venetoclax for the treatment of adults with newly diagnosed acute myeloid leukemia (AML) who are 75 years or older ...

Early lung damage mapped in children with cystic fibrosis

Researchers have mapped how lung damage begins early in life for children with cystic fibrosis, providing new insights that will help reshape future care. The research team, led by Murdoch Children's Research Institute (MCRI) ...

Dread and denial at heart of deadly DR Congo Ebola outbreak

Unlike other residents of Mongbwalu, a town at the heart of the eastern Democratic Republic of Congo's latest devastating Ebola outbreak, Laureine Sakiya believes that the blood-letting virus exists after seeing some of her ...

page 1 from 2